121 related articles for article (PubMed ID: 3619187)
1. Pharmacologic suppression of the neutrophil component of the alveolitis in idiopathic pulmonary fibrosis.
O'Donnell K; Keogh B; Cantin A; Crystal RG
Am Rev Respir Dis; 1987 Aug; 136(2):288-92. PubMed ID: 3619187
[TBL] [Abstract][Full Text] [Related]
2. Effect of intermittent high dose parenteral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis.
Keogh BA; Bernardo J; Hunninghake GW; Line BR; Price DL; Crystal RG
Am Rev Respir Dis; 1983 Jan; 127(1):18-22. PubMed ID: 6849542
[TBL] [Abstract][Full Text] [Related]
3. Colchicine, cyclophosphamide and prednisone in the treatment of mild-moderate idiopathic pulmonary fibrosis: comparison of three currently available therapeutic regimens.
Fiorucci E; Lucantoni G; Paone G; Zotti M; Li BE; Serpilli M; Regimenti P; Cammarella I; Puglisi G; Schmid G
Eur Rev Med Pharmacol Sci; 2008; 12(2):105-11. PubMed ID: 18575160
[TBL] [Abstract][Full Text] [Related]
4. Determinants of response to immunosuppressive therapy in idiopathic pulmonary fibrosis.
van Oortegem K; Wallaert B; Marquette CH; Ramon P; Perez T; Lafitte JJ; Tonnel AB
Eur Respir J; 1994 Nov; 7(11):1950-7. PubMed ID: 7875264
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease.
Silver RM; Warrick JH; Kinsella MB; Staudt LS; Baumann MH; Strange C
J Rheumatol; 1993 May; 20(5):838-44. PubMed ID: 8336309
[TBL] [Abstract][Full Text] [Related]
6. Bronchoalveolar lavage fluid neutrophils increase after corticosteroid therapy in smokers with idiopathic pulmonary fibrosis.
Watters LC; King TE; Cherniack RM; Waldron JA; Stanford RE; Willcox ML; Christopher KL; Schwarz MI
Am Rev Respir Dis; 1986 Jan; 133(1):104-9. PubMed ID: 3942366
[TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide reduces neutrophilic alveolitis in patients with scleroderma lung disease: a retrospective analysis of serial bronchoalveolar lavage investigations.
Kowal-Bielecka O; Kowal K; Rojewska J; Bodzenta-Lukaszyk A; Siergiejko Z; Sierakowska M; Sierakowski S
Ann Rheum Dis; 2005 Sep; 64(9):1343-6. PubMed ID: 16100339
[TBL] [Abstract][Full Text] [Related]
8. [Idiopathic lung fibrosis].
Schmid-Zumstein A; Bernheim R; Medici TC
Schweiz Med Wochenschr; 1988 Jun; 118(25):979-85. PubMed ID: 3045952
[TBL] [Abstract][Full Text] [Related]
9. Survival in idiopathic pulmonary fibrosis-cytotoxic agents compared to corticosteroids.
Pereira CA; Malheiros T; Coletta EM; Ferreira RG; Rubin AS; Otta JS; Rocha NS
Respir Med; 2006 Feb; 100(2):340-7. PubMed ID: 16002271
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia.
Kondoh Y; Taniguchi H; Yokoi T; Nishiyama O; Ohishi T; Kato T; Suzuki K; Suzuki R
Eur Respir J; 2005 Mar; 25(3):528-33. PubMed ID: 15738299
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
[TBL] [Abstract][Full Text] [Related]
12. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
Mittoo S; Wigley FM; Wise R; Xiao H; Hummers L
Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251
[TBL] [Abstract][Full Text] [Related]
13. Early stage of fulminant idiopathic pulmonary fibrosis cured by intense combination therapy using cyclophosphamide, vincristine, and prednisone.
Meuret G; Fueter R; Gloor F
Respiration; 1978; 36(4):228-33. PubMed ID: 674871
[TBL] [Abstract][Full Text] [Related]
14. [Hepatitis C virus and pulmonary fibrosis].
Manganelli P; Salaffi F; Pesci A
Recenti Prog Med; 2002 May; 93(5):322-6. PubMed ID: 12050917
[TBL] [Abstract][Full Text] [Related]
15. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung.
Behr J; Vogelmeier C; Beinert T; Meurer M; Krombach F; König G; Fruhmann G
Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):400-6. PubMed ID: 8756813
[TBL] [Abstract][Full Text] [Related]
16. [Long-term follow-up of lung function parameters in patients with idiopathic pulmonary fibrosis treated with prednisone and azathioprin or d-penicillamine (author's transl)].
Meier-Sydow J; Rust M; Kronenberger H; Thiel C; Amthor M; Riemann H
Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():680-8. PubMed ID: 461366
[TBL] [Abstract][Full Text] [Related]
17. Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis.
Rudd RM; Haslam PL; Turner-Warwick M
Am Rev Respir Dis; 1981 Jul; 124(1):1-8. PubMed ID: 7258815
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis.
Fireman E; Vardinon N; Burke M; Spizer S; Levin S; Endler A; Stav D; Topilsky M; Mann A; Schwarz Y; Kivity S; Greif J
Eur Respir J; 1998 Mar; 11(3):706-11. PubMed ID: 9596125
[TBL] [Abstract][Full Text] [Related]
19. Increased procollagen III aminoterminal peptide-related antigens and fibroblast growth signals in the lungs of patients with idiopathic pulmonary fibrosis.
Cantin AM; Boileau R; Bégin R
Am Rev Respir Dis; 1988 Mar; 137(3):572-8. PubMed ID: 3345038
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome].
Franzolini N; Quartuccio L; De Marchi G; De Vita S
Reumatismo; 2007; 59(3):202-8. PubMed ID: 17898879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
